We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.
OPXAW

Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

6 hedge funds and large institutions have $446K invested in Opexa Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$239K
2
SM
Sabby Management
Florida
+$81.6K
3
California Public Employees Retirement System
California Public Employees Retirement System
California
+$39.8K
4
VKH
Virtu KCG Holdings
New York
+$28.6K
5
TMC
Trellus Management Company
Florida
+$1.89K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$272K +$239K +1,600,000 New
SM
2
Sabby Management
Florida
$93K +$81.6K +545,505 New
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$45K +$39.8K +266,050 New
VKH
4
Virtu KCG Holdings
New York
$33K +$28.6K +191,436 New
TMC
5
Trellus Management Company
Florida
$2K +$1.89K +12,600 New
UBS Group
6
UBS Group
Switzerland
$1K +$1.23K +8,252 New

OPXAW Hedge Fund Activity: Q2 2015 in Review

6 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q2 2015, worth a combined $446K.

Buyers outnumbered sellers: 6 funds opened new OPXAW positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $239K.

  • 6 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $446K of Opexa Therapeutics, Inc. stock for Q2 2015.
  • 6 funds opened new Opexa Therapeutics, Inc. positions in Q2 2015 and 0 closed out, a net change of +6 holders.
  • The largest Opexa Therapeutics, Inc. buyer in Q2 2015 was Millennium Management, an estimated $239K added.

Based on aggregated 13F filings for Q2 2015.